Semi-Annual Statement Of Income And Retained Earnings

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7252445

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
99,000,000 JPY
5,773,000,000 JPY
460,000,000 JPY
4,684,000,000 JPY
636,000,000 JPY
4,684,000,000 JPY
5,881,000,000 JPY
2,627,000,000 JPY
2,627,000,000 JPY
1,064,000,000 JPY
261,000,000 JPY
4,017,000,000 JPY
81,000,000 JPY
4,035,000,000 JPY
Non-operating income
Non-operating income
1,542,000,000 JPY
1,594,000,000 JPY
2,396,000,000 JPY
2,329,000,000 JPY
Non-operating expenses
Non-operating expenses
341,000,000 JPY
385,000,000 JPY
248,000,000 JPY
203,000,000 JPY
Ordinary profit (loss)
6,974,000,000 JPY
5,893,000,000 JPY
4,776,000,000 JPY
6,142,000,000 JPY
Extraordinary income
Extraordinary income
12,033,000,000 JPY
12,033,000,000 JPY
8,349,000,000 JPY
8,349,000,000 JPY
Extraordinary losses
Extraordinary losses
3,398,000,000 JPY
3,106,000,000 JPY
43,000,000 JPY
43,000,000 JPY
Profit (loss) before income taxes
15,610,000,000 JPY
14,820,000,000 JPY
13,082,000,000 JPY
14,449,000,000 JPY
Income taxes - current
2,918,000,000 JPY
2,611,000,000 JPY
2,819,000,000 JPY
3,263,000,000 JPY
Income taxes - deferred
716,000,000 JPY
671,000,000 JPY
-44,000,000 JPY
-104,000,000 JPY
Profit (loss)
11,538,000,000 JPY
11,975,000,000 JPY
11,538,000,000 JPY
11,538,000,000 JPY
11,538,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
11,289,000,000 JPY
10,307,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.